Showing 1-10 of 14 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| ROLE OF ZBED3 IN BETA CELL STRESS RESPONSE AND VULNERABILITY AGAINST AUTOIMMUNITY | Indiana Biosciences Research Institute | Erica Cai | Cures | 01-March-2023 to 29-February-2028 | $999,737.71 |
| Targeting ER cargo proteins for beta cell protection against cellular stress and autoimmunity | Indiana Biosciences Research Institute | Erica Cai | Cures | 01-September-2023 to 31-August-2026 | $499,934.12 |
| Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D | Indiana Biosciences Research Institute | Michael Kalwat | Cures | 01-December-2024 to 30-November-2027 | $748,169.00 |
| Preclinical evaluation of SERCA2 activators for pancreatic beta-cell protection in T1D | Neurodon LLC | Russell Dahl | Cures | 01-June-2022 to 31-May-2026 | $920,000.00 |
| Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes | Trustees of Indiana University | Amelia Linnemann | Cures | 01-October-2023 to 30-September-2026 | $560,000.00 |
| β Cell Mitochondrial Health as a Driver and Indicator of Immune Activation in Type 1 Diabetes | Trustees of Indiana University | Carmella Evans-Molina | Cures | 01-March-2026 to 28-February-2029 | $748,179.00 |
| Defining the role of islet-derived extracellular vesicle PD-L1 cargo in type-1 diabetes | Trustees of Indiana University | Chaitra Rao | Cures | 01-March-2024 to 30-April-2027 | $228,537.45 |
| Optimizing Approaches to Type 1 Diabetes Prediction and Intervention in the Adult Autoantibody Positive Population | Trustees of Indiana University | Emily Sims | Cures | 01-February-2026 to 31-January-2029 | $691,694.00 |
| Targeting type 1 Diabetes through Polyamines with DFMO | Trustees of Indiana University | Emily Sims | Cures | 01-October-2022 to 30-September-2026 | $3,693,701.00 |
| Type I Interferons and B Cell Metabolism as Drivers of Type 1 Diabetes | Trustees of Indiana University | Jamie Felton | Cures | 01-February-2026 to 31-January-2029 | $682,534.00 |